Jessica L. Conway, MD, Joseph M

Slides:

Advertisements

Similar presentations

Massive Bronchogenic Cyst Joseph B. Levin, BA, Chi Wan Koo, MD, Jessica S. Donington, MD Journal of Thoracic Oncology Volume 5, Issue 11, Pages

Advertisements

Regional variation in histopathology-specific incidence of invasive cervical cancer among Peruvian women Christine M. Pierce Campbell, Maria P. Curado,

A Quantitative Analysis of the Relationship Between Radiation Therapy Use and Travel Time Emma Liu, MM, Pablo Santibáñez, MM, Martin L. Puterman, PhD,

Jeremy D. Kauffman, MD, T. Joseph Watson, MD, Joseph J. Campbell, MD

125I reimplantation in patients with poor initial dosimetry after prostate brachytherapy Mira Keyes, MD, Tom Pickles, MD, Alexander Agranovich, MD, Winkle.

Incidence of Late Rectal and Urinary Toxicities After Three-Dimensional Conformal Radiotherapy and Intensity-Modulated Radiotherapy for Localized Prostate.

Curative Treatment of Stage I Non-Small-Cell Lung Cancer in Patients With Severe COPD: Stereotactic Radiotherapy Outcomes and Systematic Review David.

COSMIC: A Regimen of Intensity Modulated Radiation Therapy Plus Dose-Escalated, Raster-Scanned Carbon Ion Boost for Malignant Salivary Gland Tumors: Results.

Non-randomized comparison between definitive concurrent chemoradiotherapy and pre- operative radiotherapy followed by surgery in patients with hypopharyngeal.

Correlation of 18F-FDG Avid Volumes on Pre–Radiation Therapy and Post–Radiation Therapy FDG PET Scans in Recurrent Lung Cancer Nadya Shusharina, PhD,

Voice Quality After Treatment of Early Vocal Cord Cancer: A Randomized Trial Comparing Laser Surgery With Radiation Therapy Leena-Maija Aaltonen, MD,

The Case for Prostate Brachytherapy in the Affordable Care Act Era

Quality of Life and Toxicity From Passively Scattered and Spot-Scanning Proton Beam Therapy for Localized Prostate Cancer Thomas J. Pugh, MD, Mark F.

A Double-Blind Placebo-Controlled Randomized Clinical Trial With Magnesium Oxide to Reduce Intrafraction Prostate Motion for Prostate Cancer Radiotherapy

John Boyle, MD, Brad Ackerson, MD, Lin Gu, MS, Chris R. Kelsey, MD

The Use of Hormone Therapy Alone Versus Hormone Therapy and Radiation Therapy for Breast Cancer in Elderly Women: A Population-Based Study Alan M. Nichol,

18Fluorodeoxyglucose PET Is Prognostic of Progression-Free and Overall Survival in Locally Advanced Pancreas Cancer Treated With Stereotactic Radiotherapy

Dose-Volume Histogram Predictors of Chronic Gastrointestinal Complications After Radical Hysterectomy and Postoperative Concurrent Nedaplatin-Based Chemoradiation.

T. Liu, J. Zhou, S. A. Woodhouse, P. B. Schiff, P. Zhang, K. S

The Pattern of Use of Hypofractionated Radiation Therapy for Early-Stage Breast Cancer in New South Wales, Australia, 2008 to 2012 Geoff P. Delaney,

Lactate-Base 1H Magnetic Spectroscopy Does Not Predict Response and Outcomes in Patients With Stage IV Head and Neck Squamous Cell Carcinoma Q. Le, A.

Higher Biologically Effective Dose of Radiotherapy Is Associated With Improved Outcomes for Locally Advanced Non–Small Cell Lung Carcinoma Treated With.

Individualized Positron Emission Tomography–Based Isotoxic Accelerated Radiation Therapy Is Cost-Effective Compared With Conventional Radiation Therapy:

Stereotactic Body Radiation Therapy for Locally Advanced and Borderline Resectable Pancreatic Cancer Is Effective and Well Tolerated Michael D. Chuong,

Close or Positive Margins After Mastectomy for DCIS: Pattern of Relapse and Potential Indications for Radiotherapy Afshin Rashtian, M.D., Shawn Iganej,

Ductal Carcinoma In Situ With Microinvasion: Prognostic Implications, Long-Term Outcomes, and Role of Axillary Evaluation Rahul R. Parikh, M.D., Bruce.

The impact of ipsilateral breast tumor recurrence on cause specific survival in DCIS patients treated with breast conserving therapy or mastectomy C.

Jerry D Slater, M. D. , Carl J Rossi, M. D. , Les T Yonemoto, M. D

Five-Year Biochemical Results, Toxicity, and Patient-Reported Quality of Life After Delivery of Dose-Escalated Image Guided Proton Therapy for Prostate.

A New Model for Imaging and Radiation Therapy Quality Assurance in the National Clinical Trials Network of the National Cancer Institute Thomas J. FitzGerald,

Continuing Risk of Ipsilateral Breast Relapse After Breast-Conserving Therapy at Long- Term Follow-up Bas Kreike, M.D., Augustinus A.M. Hart, M.Sc., Tony.

Breast-conserving therapy with partial or whole breast irradiation: Ten-year results of the Budapest randomized trial Csaba Polgár, János Fodor, Tibor.

Timing of Radiation Therapy and Chemotherapy After Breast-Conserving Surgery for Node-Positive Breast Cancer: Long-Term Results From International Breast.

Lifetime Increased Cancer Risk in Mice Following Exposure to Clinical Proton Beam– Generated Neutrons Leo E. Gerweck, PhD, Peigen Huang, MD, Hsiao-Ming.

Higher-Than-Conventional Radiation Doses in Localized Prostate Cancer Treatment: A Meta-analysis of Randomized, Controlled Trials Gustavo Arruda Viani,

Salvage Stereotactic Body Radiotherapy (SBRT) Following In-Field Failure of Initial SBRT for Spinal Metastases Isabelle Thibault, MD, Mikki Campbell,

Adjuvant Therapy in High-Risk Stage III Cutaneous Melanoma

International Journal of Radiation Oncology • Biology • Physics

Can interstitial brachytherapy compete with external beam radiotherapy in breast cancer? In response to Drs. Polgár, Major, Strnad, Inoue, and Guedea

High-Dose-Rate Brachytherapy Boost for Prostate Cancer: Comparison of Two Different Fractionation Schemes Tania Kaprealian, M.D., Vivian Weinberg, Ph.D.,

Volume 62, Issue 6, Pages (December 2012)

Clinical Parameters Associated With Pressure Ulcer Healing in Patients With Advanced Illness Vincent Maida, MD, MSc, BSc, Marguerite Ennis, PhD, PStat,

ALK FISH and IHC: You Cannot Have One without the Other

Outcomes of Second-Line Chemotherapy in Patients with Relapsed Extensive Small Cell Lung Cancer Sandra Froeschl, MD, Garth Nicholas, MD, FRCPC, Victor.

Pain in cancer survivors; filling in the gaps

Susan C. Scott, MD, Nathan A. Pennell, MD, PhD

Supplemental oxygen and surgical site infection: getting to the truth

Patterns of Care and Treatment Outcomes of Elderly Patients with Stage I Esophageal Cancer: Analysis of the National Cancer Data Base Amy C. Moreno,

Electronic Updates for JTO Readers

Isaac M. Bromberg, MD Journal of Pain and Symptom Management

Liisa Väkevä, Annamari Ranki Journal of Investigative Dermatology

Thymoma: A Population-Based Study of the Management and Outcomes for the Province of British Columbia Caroline Mariano, MD, Diana N. Ionescu, MD, Winson.

Second-line or Subsequent Systemic Therapy for Recurrent or Progressive Non-Small Cell Lung Cancer: A Systematic Review and Practice Guideline J Noble,

The Role of Patients' Expectations in the Development of Anticipatory Nausea Related to Chemotherapy for Cancer Jane T. Hickok, MD, MPH, Joseph A. Roscoe,

Effects of Chemotherapy on Survival of Elderly Patients with Small-Cell Lung Cancer: Analysis of the SEER-Medicare Database Laura C. Caprario, MD, MS,

Jeremy D. Kauffman, MD, T. Joseph Watson, MD, Joseph J. Campbell, MD

Concurrent chemotherapy and intensity modulated radiation therapy in the treatment of anal cancer: A retrospective review from a large academic center

U.S. Hospice Benefits Journal of Pain and Symptom Management

Clinical Intensity Modulated Proton Therapy for Hodgkin Lymphoma: Which Patients Benefit the Most? Georgios Ntentas, DPhil, Katerina Dedeckova, MD, Michal.

Table of contents The Journal for Nurse Practitioners

Distraction and interruption in anaesthetic practice

A Review of Learner Impact on Faculty Productivity

Reporting of Funding Sources and Conflict of Interest in the Supportive and Palliative Oncology Literature David Hui, MD, MSc, FRCPC, Akhila Reddy, MD,

Jie Huang, Juan Peng, Linlang Guo, MD, PhD

Should Never-Smokers at Increased Risk for Lung Cancer Be Screened?

The failure of breast cancer screening

Lung cancer randomized controlled trials should compare stereotactic body radiation therapy with observation, NOT surgery Raja M. Flores, MD The Journal.

Liseth L. van den Berg, MD, Theo J. Klinkenberg, MD, Harry J. M

Associations Between Physical Activity and Quality of Life in Cancer Patients Receiving Palliative Care: A Pilot Survey Sonya S. Lowe, MD, MSc, Sharon.

Robert Comis, MD, The Passing of a “Lung Man”

Presentation transcript:

Secondary Breast Cancer Risk by Radiation Volume in Women With Hodgkin Lymphoma Jessica L. Conway, MD, Joseph M. Connors, MD, Scott Tyldesley, MD, Kerry J. Savage, MD, Belinda A. Campbell, MD, Yvonne Y. Zheng, MEng, MSc, Jeremy Hamm, MSc, Tom Pickles, MD International Journal of Radiation Oncology • Biology • Physics Volume 97, Issue 1, Pages 35-41 (January 2017) DOI: 10.1016/j.ijrobp.2016.10.004 Copyright © 2016 Terms and Conditions

Fig. 1 Consort diagram. Abbreviations: BC = British Columbia; BCCA = British Columbia Cancer Agency; HL = Hodgkin lymphoma; RT = radiation therapy. ∗Numbers shown are for each exclusion criterion and total more than 100% because of patients with >1 criterion for exclusion. International Journal of Radiation Oncology • Biology • Physics 2017 97, 35-41DOI: (10.1016/j.ijrobp.2016.10.004) Copyright © 2016 Terms and Conditions

Fig. 2 Cumulative incidence: death and loss to follow-up as competing risks. Abbreviations: CO = chemotherapy only; MRT = mantle field radiation; SBC = secondary breast cancer; SFRT = small field radiation. International Journal of Radiation Oncology • Biology • Physics 2017 97, 35-41DOI: (10.1016/j.ijrobp.2016.10.004) Copyright © 2016 Terms and Conditions